Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01944137 · ClinicalTrials.gov registry record · NA
Improving Care After Chemotherapy
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT01944137: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01944137 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01944137, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
The main purpose of this study is to examine changes in patient-reported symptoms during the first two cycles of neoadjuvant or adjuvant chemotherapy for non-small cell lung cancer (NSCLC), colorectal cancer (CRC) and breast cancer, among patients who receive standard care plus a proactive nursing intervention relative to patients who receive standard care alone. Interventions to improve symptom management and prevent urgent care needs in both the clinic and hospital for patients receiving chemotherapy with curative intent are needed to enhance the quality of cancer care.
Interventions
- OTHER Nursing Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2013-09 |
| Est. Completion | 2017-02-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01944137
The ClinicalTrials.gov registry entry for NCT01944137 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nursing Intervention is the first listed.
NCT01944137 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01944137 about?
NCT01944137 is a clinical study titled "Improving Care After Chemotherapy". The main purpose of this study is to examine changes in patient-reported symptoms during the first two cycles of neoadjuvant or adjuvant chemotherapy for non-small cell lung cancer (NSCLC), colorectal cancer (CRC) and breast cancer, among patients who receive standard care plus a proactive nursing i...
What is the current status of trial NCT01944137?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2013-09. Estimated completion is 2017-02-02.
What interventions are being tested in trial NCT01944137?
The interventions under investigation include: Nursing Intervention (OTHER).
Who is sponsoring clinical trial NCT01944137?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.